Using a nuclear magnetic resonance technique, University of Illinois at Chicago (UIC) chemists have obtained the first molecular-level images of precursors of bundled fibrils that form the brain
The results of this collaboration may help Abbott’s drug discovery programs develop drugs that are effective for a wider range of patients. Abbott will fund the research under
The Ginkgo biloba extract EGb 761 was tested in a placebo controlled study in 395 outpatients with mild to moderate dementia and neuropsychiatric symptoms such as depressed mood,
This is in spite of the fact that adult HIV infection rates have actually decreased in certain countries and that changes in behavior to prevent infection such as
The lawsuit is in response to an abbreviated new drug application filed by Ranbaxy with the FDA to market a generic version of Nexium in the US prior
The two unnamed pharmaceutical firms manufacture a number of products, including injectables and tablets. Revenues from the two firms to be acquired are expected to be an aggregate
The three-month delay will allow the FDA sufficient time to review an amendment to Somerset’s new drug application (NDA) submitted following the recommendations of the FDA’s psychopharmacologic drug
Factive is currently approved by the FDA for the five-day treatment of acute bacterial exacerbations of chronic bronchitis and in a seven-day treatment regimen for mild to moderate
The efficacy of the drug as a treatment for panic disorder was established in two 12-week, placebo-controlled studies. Adult patients received fixed doses of 75 or 150mg/day in
Wyeth has agreed to extend the research term by one year to February 9, 2007. Curis expects Wyeth to select a development candidate in the next twelve to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.